Masami Nishio

Comparison of Atorvastatin 5 and 20 mg/d for Reducing F-18 Fluorodeoxyglucose Uptake in Atherosclerotic Plaques on Positron Emission Tomography/Computed Tomography: A Randomized, Investigator-Blinded, Open-Label, 6-Month Study in Japanese Adults Scheduled for Percutaneous Coronary Intervention

Hideki Ishii, Masami Nishio, Hiroshi Takahashi et al. · Clinical Therapeutics · 2010 · 81 citations

Atorvastatin 5, Percutaneous Coronary Intervention, Vascular Disease +12

Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson's disease

Wataru Sako, Masami Nishio, Tomoyuki Maruo et al. · Movement Disorders · 2009 · 74 citations

Neuromodulation Therapies, Social Sciences, Neurobiology Of Disease +16

Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey

Ryogo Minamimoto, Michio Senda, Kimiichi Uno et al. · Annals of Nuclear Medicine · 2007 · 66 citations

Positron Emission Tomography, Medical Imaging, Cancer Detection +13

Is ¹⁸F‐fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?

Minoru Shigekawa, Kenji Yamao, Akira Sawaki et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2009 · 49 citations

FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma

Hidenori Suzuki, Yasuhisa Hasegawa, Akihiro Terada et al. · Oral Oncology · 2008 · 48 citations

Distant Metastasis, Medicine, Pathology +5